Cite
HARVARD Citation
Aitken, K. et al. (n.d.). 76: Patterns of extra-cranial disease progression in epidermal growth factor receptor (EGFR) mutant metastatic non-small cell lung cancer (NSCLC) patients on a tyrosine kinase inhibitor (TKI). Lung cancer. pp. S30-. [Online].